BlackRock Health Sciences Term Trust (NYSE:BMEZ) Stock Position Decreased by Rivernorth Capital Management LLC

Rivernorth Capital Management LLC lessened its holdings in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 10.8% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,763,415 shares of the company’s stock after selling 212,992 shares during the period. BlackRock Health Sciences Term Trust accounts for approximately 1.4% of Rivernorth Capital Management LLC’s holdings, making the stock its 22nd biggest position. Rivernorth Capital Management LLC’s holdings in BlackRock Health Sciences Term Trust were worth $27,932,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of BMEZ. Brown Brothers Harriman & Co. bought a new stake in shares of BlackRock Health Sciences Term Trust during the 3rd quarter valued at about $32,000. Register Financial Advisors LLC grew its position in shares of BlackRock Health Sciences Term Trust by 5,365.6% during the 2nd quarter. Register Financial Advisors LLC now owns 6,832 shares of the company’s stock valued at $105,000 after buying an additional 6,707 shares during the last quarter. Shaker Financial Services LLC bought a new stake in shares of BlackRock Health Sciences Term Trust during the 2nd quarter valued at about $184,000. Comerica Bank grew its position in shares of BlackRock Health Sciences Term Trust by 31.1% during the 1st quarter. Comerica Bank now owns 15,469 shares of the company’s stock valued at $254,000 after buying an additional 3,671 shares during the last quarter. Finally, Dakota Wealth Management boosted its stake in BlackRock Health Sciences Term Trust by 5.3% during the 2nd quarter. Dakota Wealth Management now owns 18,242 shares of the company’s stock valued at $280,000 after purchasing an additional 915 shares during the period.

Insider Buying and Selling at BlackRock Health Sciences Term Trust

In other news, major shareholder Saba Capital Management, L.P. bought 15,455 shares of BlackRock Health Sciences Term Trust stock in a transaction on Thursday, September 19th. The stock was purchased at an average cost of 16.14 per share, with a total value of 249,443.70. Following the purchase, the insider now directly owns 20,601,568 shares of the company’s stock, valued at approximately 332,509,307.52. This trade represents a 0.08 % increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Insiders bought 99,630 shares of company stock valued at $1,585,113 in the last ninety days.

BlackRock Health Sciences Term Trust Price Performance

BlackRock Health Sciences Term Trust stock opened at 15.57 on Thursday. The firm has a 50-day moving average price of 15.63 and a two-hundred day moving average price of 15.60. BlackRock Health Sciences Term Trust has a 52-week low of 14.08 and a 52-week high of 16.59.

BlackRock Health Sciences Term Trust Dividend Announcement

The company also recently announced a monthly dividend, which was paid on Friday, November 29th. Shareholders of record on Friday, November 15th were paid a dividend of $0.1769 per share. This represents a $2.12 dividend on an annualized basis and a yield of 13.63%. The ex-dividend date was Friday, November 15th.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.